A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...

Stocks closed mostly higher on Tuesday after the release of encouraging inflation data, adding to big gains posted the ...

Two biotech stocks make perfect candidates for this sort of strategy right now. Let's take a close look at these two biotech ...

The S&P 500 and Nasdaq 100 gained on Tuesday, with both indexes in positive territory year-to-date for the first time since ...

But now that worries about tariffs are fading, these stocks don’t look quite as attractive—especially as long-term bond ...

A new report from Morningstar compares the classic 60/40 investment mix to an all-stock portfolio, with surprising results.

US-China trade truce euphoria is giving way to worry over economic slowdown in the wait for the latest US consumer inflation ...

A deal with China is a relief to investors who worried 145% tariffs would severely limit trade, raise prices and hurt the US ...

Investors have been buying up dividend stocks in droves in recent months due to broader market volatility. This doesn’t ...

British stocks ended mixed on Tuesday, as investors assessed a tick up in U.S. inflation data, while signs of a cooling UK ...

Foreign stocks in developed markets ex-US are still the global performance leader by far in 2025, based on a set of ETFs ...

ACM Research (NASDAQ: ACMR) is a U.S.-based company, but it sells its products extensively in China. The stock surged nearly ...